(Q34362205)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22855139%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Recombinant human endostatin could eliminate the pro-angiogenesis priority of SP cells sorted from non-small cell lung cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22855139%20AND%20SRC:MED&resulttype=core&format=json

non-small-cell lung carcinoma

9 February 2020

main subject

1 reference

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22855139%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Baoshan Cao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22855139%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Jun Jia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22855139%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Liwen Ma

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22855139%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Lijun Di

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22855139%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Guohong Song

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22855139%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Yanhua Yuan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22855139%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Bo Ma

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22855139%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Yulin Zhu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22855139%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Jing Yu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22855139%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Xiaoli Wang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22855139%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Xinna Zhou

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22855139%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Jun Ren

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22855139%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

21 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22855139%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Translational Oncology

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22855139%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22855139%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22855139%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

575-585

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22855139%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12094-012-0844-9

9 February 2020

exact match

0 references

cites work

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

21 January 2018

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Applying the principles of stem-cell biology to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Tissue repair and stem cell renewal in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Cancerous stem cells can arise from pediatric brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

What Is the Evidence That Tumors Are Angiogenesis Dependent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Vascular-specific growth factors and blood vessel formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Molecular and biological properties of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Cancer stem cells and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Cancer stem cells and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Characterization of a stem cell population in lung cancer A549 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

A distinct "side population" of cells with high drug efflux capacity in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Angiogenesis inhibitors: current strategies and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

New antiangiogenetic agents and non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Identification of human pancreatic cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Identification and expansion of the tumorigenic lung cancer stem cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0844-9

[Randomized phase II trial on escalated doses of Rh-endostatin (YH-16) for advanced non-small cell lung cancer].

21 January 2018

1 reference

12 December 2020

Detection and enrichment of hematopoietic stem cells by side population phenotype

1 reference

12 December 2020

Angiogenesis and current antiangiogenic strategies for the treatment of cancer

1 reference

12 December 2020

Analysis of cavitation of advanced NSCLC treated by rh-endostatin combined with NP chemotherapy

1 reference

12 December 2020

Lung cancer: diagnosis and management.

1 reference

12 December 2020

10.1007/S12094-012-0844-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22855139%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference